Fundraising Fox
/Companies
Sign in

BioOra

New Zealand, NZ · 3 known investors

Find your way into BioOra

BioOra develops and manufactures CAR-T cell therapies from New Zealand, targeting patients with cancer who currently lack access to these treatments in their local regions. The company aims to improve treatment access, reduce delays, and enable scalable delivery of advanced cell therapies across underserved regions globally.

BiotechDigital HealthMedical Devices

Investors · 3

Bridgewest Ventureslisted by Bridgewest VenturesAuckland

How we know: Bridgewest Ventures's portfolio page · funding news · nbr.co.nz · Not right? Tell us

Cure Kids Ventureslisted by Cure Kids VenturesAuckland

How we know: Cure Kids Ventures's portfolio page · Not right? Tell us

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

BioOra signs new global rights deal ahead of $30m fund raise - NBR | Business news & analysis | Independent, ad-free reportingnbr.co.nz · Apr 2026Biotech company BioOra triples its valuation in latest raise - NBR | Business news & analysis | Independent, ad-free reportingnbr.co.nz · Oct 2025

Frequently asked questions

What does BioOra do?
BioOra develops and manufactures CAR-T cell therapies from New Zealand, targeting patients with cancer who currently lack access to these treatments in their local regions. The company aims to improve treatment access, reduce delays, and enable scalable delivery of advanced cell therapies across underserved regions globally.
Who are BioOra's investors?
BioOra's investors include Booster Innovation Fund, Bridgewest Ventures, Cure Kids Ventures.
Where is BioOra headquartered?
BioOra is headquartered in New Zealand, NZ.